Skip to content

BCG bladder treatment after TURBT

Who it is for, what each instillation is like, the guideline schedule, the side effects and follow-up.

Dr. Petronio Melo, urologistA reference in robotic surgery for kidney and bladder tumors
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 20, 2026
Book a consultation
Drawing of the bladder in cross-section, filled with a milky liquid carrying BCG bacilli, with a thin catheter through the urethra and, beside it, a magnifier showing the bacilli against the inner lining, a flat patch of tumor cells and immune cells rising from the layer below to surround them
On this page

Quick answer

BCG is an immunotherapy placed inside the bladder through a catheter, after TURBT, for tumors that do not invade the muscle and are intermediate or high risk.1 It lowers the chance of the tumor coming back and progressing.1,4 The schedule starts with 6 weekly instillations and continues with maintenance series for 1 to 3 years, depending on the risk.1 The European guideline does not allow starting in the first 2 weeks after TURBT.1 In my practice, I recommend starting 6 to 8 weeks after TURBT, and I follow the European guideline for maintenance. Burning, needing to urinate often and flu-like symptoms for 2 or 3 days are common.3

What BCG is

BCG is the tuberculosis vaccine. It is made with live bacteria, weakened to reduce the risk of infection. Placed inside the bladder, it stimulates the immune cells of the wall to attack the cancer cells.3 That is why it counts as an immunotherapy.

The European guideline cites 5 meta-analyses showing that BCG after TURBT prevents recurrence better than TURBT alone or TURBT with chemotherapy in the bladder.1 In a review of 4,863 patients, the tumor progressed, meaning it went on to invade the muscle, in 9.8% of those given BCG and in 13.8% of the other groups, a 27% reduction in the odds of progression.4 This benefit only appeared in those who had maintenance, and there was no difference in overall survival.4

Who it is for

After TURBT, the pathology report gives the stage and grade of the tumor, and the European guideline divides tumors that do not invade the muscle into risk groups.1 What each result means is explained in is a bladder tumor serious? and bladder cancer.

RiskWhat the European guideline advises
LowBCG is not part of the recommendations; follow-up is with cystoscopy1,2
IntermediateChemotherapy in the bladder as the first option, or 1 year of BCG as the alternative1
HighFull-dose BCG for 1 to 3 years1
Very highRemoval of the bladder, or BCG for 1 to 3 years for those who do not want or cannot have surgery1

Carcinoma in situ, a flat lesion of the inner lining, cannot be treated by TURBT alone: the guideline recommends BCG or removal of the bladder.1 In intermediate risk, the choice between chemotherapy and BCG depends on the case and is discussed with the patient. The American guideline (AUA/SUO), updated in 2026, also organizes treatment by risk group and revised its statements on BCG maintenance.7

When to start after TURBT

The European guideline lists 4 situations in which BCG must not be given:1

  • In the first 2 weeks after TURBT
  • With visible blood in the urine
  • After a traumatic catheter insertion
  • With a urinary infection that causes symptoms

In my practice, I recommend starting BCG 6 to 8 weeks after TURBT. The care in the first weeks after the resection is explained in TURBT recovery. When a second TURBT is needed, it is usually done 2 to 6 weeks after the first.1

What each instillation is like

The British Association of Urological Surgeons leaflet describes the instillation like this:3

  1. BeforeLimit fluids for the previous 6 hours. On arrival, your urine is tested; if there are signs of infection, the instillation may be postponed while you take antibiotics.
  2. The catheterAfter the area is cleaned, a gel with local anesthetic goes into the urethra, and a thin catheter is passed into the bladder.
  3. The BCGAbout half a cupful of BCG liquid goes in through the catheter, and the catheter is removed straight away.
  4. Holding itTry not to pass urine for 2 hours, so the medicine treats the whole bladder lining.

Allow up to 3 hours the first time. After that, each instillation takes about 30 minutes.3 In my practice, I give BCG in the hospital.

Urine precautions. The urine carries live BCG bacteria. For up to 6 hours after each instillation, urinate sitting down to avoid splashing. After urinating, pour undiluted household bleach into the toilet, the same amount as the urine, and wait 15 minutes before flushing.3 Over the next few days, wash your hands and genitals every time you urinate and drink 2 to 3 liters of fluid a day.3

Sex. The leaflet advises avoiding sex for 24 hours after each instillation, because it can be uncomfortable, and using a condom throughout treatment and for 1 week after.3

Induction and maintenance

  1. Induction6 instillations, one a week1,3
  2. 3, 6 and 12 monthsSeries of 3 instillations, one a week. This is the first year of maintenance1
  3. 18, 24, 30 and 36 monthsFurther series of 3 weekly instillations, in the full 3-year schedule1,5

In intermediate risk, the guideline speaks of 1 year of BCG: induction and series at 3, 6 and 12 months. In high risk, 1 to 3 years, and the gain of the second and third years is weighed against the side effects and the cost.1 A cystoscopy is done before each maintenance series.3

Maintenance makes a difference. In the American trial that tested this schedule, the median time without recurrence was 35.7 months without maintenance and 76.8 months with it.5 Cutting the schedule also has a cost: in one trial, 3 instillations in induction and 2 in each maintenance series were worse than the standard schedule, and one-third dose led to more recurrence, especially when given for only 1 year.1

In my practice, I follow the European guideline for the maintenance schedule.

Side effects

Most side effects appear in the first few days after each instillation and settle on their own.3 In a European study of 1,316 patients, 62.8% had some local side effect and 30.6% some whole-body side effect. The most frequent were bladder inflammation, in 35%, and general malaise, in 15.5%.6

Side effectFrequency in the British leaflet
Burning, bladder discomfort, needing to urinate often (up to 3 days)Between 1 in 2 and 1 in 10 patients3
Flu-like symptoms for 2 to 3 daysBetween 1 in 2 and 1 in 10 patients3
Blood or debris in the urineBetween 1 in 2 and 1 in 10 patients3
Urinary infection, which usually postpones the next doseBetween 1 in 2 and 1 in 10 patients3
Narrowing of the urethra from repeated cathetersBetween 1 in 10 and 1 in 50 patients3
Inflammation of the liver, joints or back of the eyeBetween 1 in 10 and 1 in 50 patients3
Generalized BCG infection, needing hospital treatmentBetween 1 in 50 and 1 in 250 patients3

Generalized BCG infection is not tuberculosis, and there is no risk of catching tuberculosis from the treatment.3 The European guideline reports serious side effects in less than 5% of patients and generalized infection in 1% to 2%.1

When to postpone or stop

Side effects are the main reason for not completing the schedule.3 More than half of patients do not complete 1 year of maintenance, and in the European study 7.8% stopped because of side effects, mostly in the first year.1,6 The European guideline sets out what to do in each situation:1

  • Bladder inflammation that does not settle. The instillation is postponed, the urine is sent for culture and antibiotics start if the symptoms persist.
  • High fever that does not settle. BCG is stopped for good.
  • Prostate inflammation from BCG, with symptoms. Treatment in the bladder is stopped.
  • Generalized BCG infection. BCG is stopped.

The guideline also cites a review in which an antibiotic from the quinolone group reduced the stronger side effects, and it recommends offering it with caution.1

Follow-up with cystoscopy

A bladder tumor can come back during or after BCG, so cystoscopy is part of the treatment.3 The first one is done 3 months after TURBT, and its result helps predict recurrence and progression.2

RiskCystoscopy, by the European guideline
IntermediateAt 3 months; then every 6 months for 2 years and once a year up to 10 years2
High and very highAt 3 months, with urine cytology; then every 3 months for 2 years, every 6 months until year 5 and once a year for life2

In high risk, the guideline also advises a CT scan of the urinary tract, which shows the kidneys and ureters, once a year.2 Stopping smoking is part of treatment, because smoking encourages the tumor to come back.1,3

When the tumor does not respond to BCG

The European guideline calls a tumor BCG-unresponsive when a high-grade tumor comes back within 6 months after adequate BCG, or carcinoma in situ comes back within 12 months.1 In these cases, it recommends offering cystectomy, removal of the bladder.1

For those who cannot or do not want surgery, the guideline cites bladder-sparing treatments, such as chemotherapy in the bladder, preferably within clinical trials.1 The decision is discussed with the patient, with the risks of each path on the table.

How I approach it

In my practice, when BCG is indicated, I recommend starting it 6 to 8 weeks after TURBT. The European guideline only forbids starting in the first 2 weeks. For the maintenance schedule, I follow the European guideline. The instillations are given in the hospital. I take time to explain the pathology result and the risk group, because that is where the indication for BCG comes from, and the decision is made together with the patient.

When to contact me

  • If you have a fever or chills
  • If the burning and the need to urinate last more than 3 days or get worse
  • If the blood in the urine is heavy or comes with clots
  • If you notice joint pain, a red eye or yellowish skin
  • If you cannot urinate

In these cases, contact me the same day.

Send your case

If you have had a TURBT and would like my opinion on BCG in your case before a consultation, fill in the form below. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

What is BCG bladder treatment?

It is an immunotherapy placed inside the bladder through a catheter. BCG is the tuberculosis vaccine, made with weakened live bacteria that stimulate the immune cells of the bladder to attack the cancer cells.3 It lowers the chance of the tumor coming back and progressing after TURBT.1,4

Who is BCG recommended for?

For bladder tumors that do not invade the muscle and are intermediate or high risk, according to the European guideline. In high risk, BCG is given for 1 to 3 years. In intermediate risk, chemotherapy in the bladder is usually the first option, and 1 year of BCG is the alternative. In very high risk, removing the bladder is the main option, and BCG is for those who do not want or cannot have surgery.1

How long after TURBT does BCG start?

The European guideline does not allow BCG in the first 2 weeks after TURBT, with visible blood in the urine or with a urinary infection that causes symptoms.1 In my practice, I recommend starting BCG 6 to 8 weeks after TURBT.

How many BCG instillations are given?

Induction has 6 instillations, one a week. Maintenance has series of 3 weekly instillations at 3, 6, 12, 18, 24, 30 and 36 months, in the full 3-year schedule.1,5 In intermediate risk, the guideline speaks of 1 year: induction and series at 3, 6 and 12 months.1 In my practice, I follow the European guideline for the maintenance schedule.

How long do I need to hold BCG in my bladder?

The British Association of Urological Surgeons advises trying not to pass urine for 2 hours after the instillation, so the medicine treats the whole bladder lining. Before it, they ask you to limit fluids for the previous 6 hours.3

What are the side effects of BCG?

Burning, needing to urinate often, blood in the urine and flu-like symptoms for 2 or 3 days are common.3 In a European study of 1,316 patients, 62.8% had some local side effect and 30.6% some whole-body side effect, and 7.8% stopped treatment because of them.6 Serious side effects occur in less than 5%, and generalized BCG infection in 1% to 2%.1

What precautions should I take with my urine after BCG?

For up to 6 hours after each instillation, urinate sitting down to avoid splashing. After urinating, pour undiluted household bleach into the toilet, the same amount as the urine, and wait 15 minutes before flushing. Wash your hands and genitals every time you urinate over the next few days and drink 2 to 3 liters of fluid a day for the first few days.3

What if the tumor comes back despite BCG?

When a high-grade tumor comes back within 6 months after adequate BCG, or carcinoma in situ comes back within 12 months, the European guideline calls the tumor "BCG-unresponsive" and recommends offering removal of the bladder. For those who cannot or do not want surgery, there are bladder-sparing treatments, preferably within clinical trials.1

References

  1. EAU Guidelines on Non-muscle-invasive Bladder Cancer. European Association of Urology; 2026. Disease management chapter. EAU
  2. EAU Guidelines on Non-muscle-invasive Bladder Cancer. European Association of Urology; 2026. Follow-up chapter. EAU
  3. British Association of Urological Surgeons. Intravesical BCG for bladder cancer. Leaflet O24/001, published July 2024. BAUS
  4. Sylvester RJ, van der Meijden AP, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol. 2002;168(5):1964-70. PubMed
  5. Lamm DL, Blumenstein BA, Crissman JD, et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol. 2000;163(4):1124-9. PubMed
  6. Brausi M, Oddens J, Sylvester R, et al. Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG. Eur Urol. 2014;65(1):69-76. PubMed
  7. Clark PE, Holzbeierlein J, Chang SS, et al. 2026 Updates to the Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline. J Urol. 2026. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides